Polypeptides for inducing a protective immune response against Staphylococcus aureus
Details for Australian Patent Application No. 2004258979 (hide)
International Classifications
Event Publications
16 February 2006 PCT application entered the National Phase
PCT publication WO2005/009379 Priority application(s): WO2005/009379
6 December 2007 Application Accepted
Published as AU-B-2004258979
3 April 2008 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004258980-Negative pressure wound treatment dressing
2004258974-Stable aluminum/zirconium antiperspirant solution
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser